Your search returned 4 results.

Results
	1.	Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis. [electronic resource] by Cioffi, Christopher L Racz, Boglarka Varadi, Andras Freeman, Emily E Conlon, Michael P Chen, Ping Zhu, Lei Kitchen, Douglas B Barnes, Keith D Martin, William H Pearson, Paul G Johnson, Graham Blaner, William S Petrukhin, Konstantin Producer: 20200615 In: Journal of medicinal chemistry vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease. [electronic resource] by Cioffi, Christopher L Racz, Boglarka Freeman, Emily E Conlon, Michael P Chen, Ping Stafford, Douglas G Schwarz, Daniel M C Zhu, Lei Kitchen, Douglas B Barnes, Keith D Dobri, Nicoleta Michelotti, Enrique Cywin, Charles L Martin, William H Pearson, Paul G Johnson, Graham Petrukhin, Konstantin Producer: 20151208 In: Journal of medicinal chemistry vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt disease. [electronic resource] by Cioffi, Christopher L Dobri, Nicoleta Freeman, Emily E Conlon, Michael P Chen, Ping Stafford, Douglas G Schwarz, Daniel M C Golden, Kathy C Zhu, Lei Kitchen, Douglas B Barnes, Keith D Racz, Boglarka Qin, Qiong Michelotti, Enrique Cywin, Charles L Martin, William H Pearson, Paul G Johnson, Graham Petrukhin, Konstantin Producer: 20141203 In: Journal of medicinal chemistry vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Lead optimization toward proof-of-concept tools for Huntington's disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitors. [electronic resource] by Wityak, John McGee, Kevin F Conlon, Michael P Song, Ren Hua Duffy, Bryan C Clayton, Brent Lynch, Michael Wang, Gwen Freeman, Emily Haber, James Kitchen, Douglas B Manning, David D Ismail, Jiffry Khmelnitsky, Yuri Michels, Peter Webster, Jeff Irigoyen, Macarena Luche, Michele Hultman, Monica Bai, Mei Kuok, IokTeng D Newell, Ryan Lamers, Marieke Leonard, Philip Yates, Dawn Matthews, Kim Ongeri, Lynette Clifton, Steve Mead, Tania Deupree, Susan Wheelan, Pat Lyons, Kathy Wilson, Claire Kiselyov, Alex Toledo-Sherman, Leticia Beconi, Maria Muñoz-Sanjuan, Ignacio Bard, Jonathan Dominguez, Celia Producer: 20150630 In: Journal of medicinal chemistry vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)